China · Delayed Price · Currency is CNY Beijing SL Pharmaceutical Statistics
Total Valuation
SHE:002038 has a market cap or net worth of CNY 6.06 billion. The enterprise value is 4.83 billion.
| Market Cap | 6.06B |
| Enterprise Value | 4.83B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | Jul 22, 2026 |
Share Statistics
SHE:002038 has 1.03 billion shares outstanding. The number of shares has decreased by -3.96% in one year.
| Current Share Class | 1.03B |
| Shares Outstanding | 1.03B |
| Shares Change (YoY) | -3.96% |
| Shares Change (QoQ) | -10.43% |
| Owned by Insiders (%) | 23.19% |
| Owned by Institutions (%) | 2.87% |
| Float | 629.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.63 |
| PB Ratio | 1.23 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | 12.27 |
| P/OCF Ratio | 10.86 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.39, with an EV/FCF ratio of 9.79.
| EV / Earnings | n/a |
| EV / Sales | 8.47 |
| EV / EBITDA | 33.39 |
| EV / EBIT | n/a |
| EV / FCF | 9.79 |
Financial Position
The company has a current ratio of 7.78
| Current Ratio | 7.78 |
| Quick Ratio | 6.54 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -13.63% and return on invested capital (ROIC) is -0.59%.
| Return on Equity (ROE) | -13.63% |
| Return on Assets (ROA) | -0.25% |
| Return on Invested Capital (ROIC) | -0.59% |
| Return on Capital Employed (ROCE) | -0.44% |
| Weighted Average Cost of Capital (WACC) | 3.40% |
| Revenue Per Employee | 632,923 |
| Profits Per Employee | -802,798 |
| Employee Count | 901 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 0.80 |
Taxes
In the past 12 months, SHE:002038 has paid 12.76 million in taxes.
| Income Tax | 12.76M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.87% in the last 52 weeks. The beta is -0.15, so SHE:002038's price volatility has been lower than the market average.
| Beta (5Y) | -0.15 |
| 52-Week Price Change | -23.87% |
| 50-Day Moving Average | 6.05 |
| 200-Day Moving Average | 6.66 |
| Relative Strength Index (RSI) | 46.63 |
| Average Volume (20 Days) | 47,667,781 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002038 had revenue of CNY 570.26 million and -723.32 million in losses. Loss per share was -0.70.
| Revenue | 570.26M |
| Gross Profit | 348.31M |
| Operating Income | -22.41M |
| Pretax Income | -711.88M |
| Net Income | -723.32M |
| EBITDA | 144.71M |
| EBIT | -22.41M |
| Loss Per Share | -0.70 |
Balance Sheet
The company has 1.24 billion in cash and no debt, with a net cash position of 1.24 billion or 1.20 per share.
| Cash & Cash Equivalents | 1.24B |
| Total Debt | n/a |
| Net Cash | 1.24B |
| Net Cash Per Share | 1.20 |
| Equity (Book Value) | 4.93B |
| Book Value Per Share | 5.11 |
| Working Capital | 1.37B |
Cash Flow
In the last 12 months, operating cash flow was 558.39 million and capital expenditures -64.56 million, giving a free cash flow of 493.83 million.
| Operating Cash Flow | 558.39M |
| Capital Expenditures | -64.56M |
| Depreciation & Amortization | 167.12M |
| Net Borrowing | n/a |
| Free Cash Flow | 493.83M |
| FCF Per Share | 0.48 |
Margins
Gross margin is 61.08%, with operating and profit margins of -3.93% and -126.84%.
| Gross Margin | 61.08% |
| Operating Margin | -3.93% |
| Pretax Margin | -124.83% |
| Profit Margin | -126.84% |
| EBITDA Margin | 25.38% |
| EBIT Margin | -3.93% |
| FCF Margin | 86.60% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.17%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.17% |
| Dividend Growth (YoY) | -50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.96% |
| Shareholder Yield | 4.13% |
| Earnings Yield | -11.93% |
| FCF Yield | 8.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 4, 2019. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 4, 2019 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |